Hovedindeksen (OSEBX.OL)

Close: 666.86 (-25.18), Mar 27, 2020
Negative

Low risk

Automatic technical analysis. Medium term, Mar 27, 2020

Hovedindeksen has broken the rising trend channel in the medium long term and reacted strongly down. For the time being, it is difficult to say anything about the future trend direction. There is no support in the price chart and further decline is indicated. In case of a positive reaction, the index has resistance at 856 points. The index is assessed as technically negative for the medium long term.

Recommendation one to six months: Negative (Score: -71)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.85%6 639.13-3.64%
5 days50.482.77%7 827.68-0.29%
22 days1.747.06%9 865.78-24.77%
66 days-25.5011.48%6 791.15-27.72%

More analyses of Hovedindeksen

chart Hovedindeksen (OSEBX) Candlesticks 22 Days
Candlesticks
chart Hovedindeksen (OSEBX) Short term
Short term: Weak Negative
chart Hovedindeksen (OSEBX) Medium term
Medium term: Negative
chart Hovedindeksen (OSEBX) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK